Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axillary Reverse Mapping (ARM): Validation of Surgical Tecnique in Breast Cancer Surgery

NCT05040685 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT05040685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axillary Reverse Mapping (ARM): Validation of Surgical Tecnique in Breast Cancer Surgery
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2021
Completion date
July 1, 2023
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node cancer metastatic